Brief: Onesource Specialty Pharma Approves Consolidation Of Singapore Business Ops
05/05/2025 16:30
May 5 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS: APPROVES CONSOLIDATION OF SINGAPORE BUSINESS OPERATIONS MARCH-QUARTER CONSOL PROFIT 985 MILLION RUPEES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.26 BILLION RUPEES Source text: ID:nBSEbRgFgV Further company coverage: ONEO.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Onesource Specialty Pharma
See all newsBrief: Onesource Specialty Pharma Not To Pursue Merger Of Facilities Of Steriscienceat With Co
Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
Brief: Onesource Specialty Pharma Says Orbicular Secures Tentative U.S. FDA ANDA Approval For Generic Ozempic
Brief: Onesource Specialty Pharma Says EU-GMP Certification For Unit II Manufacturing Facility Renewed
Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia